Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names ...

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR ® (deutetrabenazine) extended-release tablets Patients reported ...

FDA Approves NUCYNTA ® ER (tapentadol) Extended-Release Oral Tablets for the Management of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy Clinical Trial Data Demonstrate Efficacy and ...

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved XELJANZ® XR (tofacitinib) extended-release 11 mg and 22 mg tablets for the once-daily treatment of ...

However, a new drug may finally change all that. Veradermics, a Connecticut-based biopharmaceutical company, is developing a new drug specifically for androgenetic alopecia, or pattern hair loss, in ...

Patients prescribed the 30mg dose who receive the 60mg dose may potentially be at risk for overdose and death. Bryant Ranch Prepack Inc. has voluntarily recalled 1 lot of Morphine Sulfate 30mg ...

AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...

October 7, 2010 — The US Food and Drug Administration (FDA) has approved clonidine hydrochloride, 0.1-mg and 0.2-mg, extended-release tablets (Kapvay; Shionogi Inc ...

WASHINGTON, D.C. (WRIC) — Virginians who take morphine to manage pain are asked to check their bottles after a voluntary recall. Bryant Ranch Prepack, Inc. is voluntarily recalling one lot of 30mg ...

The FDA on Thursday approved Xeljanz extended release 11 mg and 22 mg tablets for the once daily treatment of adults with moderately to severely active ulcerative colitis, following an inadequate ...